Liposarcoma, fibrosarcoma, angiosarcoma, leiomyosarcoma, rhabdomyosarcoma, mesenchymoma, extraosseous osteosarcoma, synovial sarcoma, epithelioid sarcoma, soft tissue clear cell sarcoma, extraosseous myxoid chondrosarcoma, endometrial stromal sarcoma, undifferentiated sarcoma, pleomorphic sarcoma, round cell sarcoma, myofibroblastic sarcoma, Kaposi's sarcoma, inflammatory myofibroblastic tumor, my
Conditions
Interventions
Sponsors
Xiang'an Hospital of Xiamen University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Pathological examination confirmed the diagnosis of tumors of the following pathological types: liposarcoma, fibrosarcoma, angiosarcoma, leiomyosarcoma, rhabdomyosarcoma, mesenchymoma, extraosseous osteosarcoma, synovial sarcoma, epithelioid sarcoma, soft tissue clear cell sarcoma, extraosseous myxoid chondrosarcoma, endometrial stromal sarcoma, undifferentiated sarcoma, pleomorphic sarcoma, round cell sarcoma, myofibroblastoma, Kaposi's sarcoma, inflammatory myofibroblastic tumor, myxoinflammatory fibroblastic sarcoma, solitary fibrous tumor, malignant giant cell tumor of the tendon sheath, malignant hemangiopericytoma, malignant peripheral nerve sheath tumor, malignant granular cell tumor, malignant schwannoma, small round cell tumor, gastrointestinal stromal tumor (GIST), perivascular epithelioid cell tumor (PEComa), ossifying fibromyxoid tumor, and myoepithelial carcinoma.
Exclusion criteria
Exclusion criteria: 1.Clinical data or follow-up information is incomplete.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-Free Survival; | — |
Countries
China
Contacts
Public ContactWengang Li
Xiang'an Hospital of Xiamen University
Outcome results
None listed